Cart
sales@molnova.com
Recilisib
CAS No. 334969-03-8
Recilisib ( Ex-RAD; ON 01210 )
Catalog No. M24278 CAS No. 334969-03-8
Recilisib is a radioprotectant,can activate AKT, PI3K activities in cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 80 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 500MG | 1098 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRecilisib
-
NoteResearch use only, not for human use.
-
Brief DescriptionRecilisib is a radioprotectant,can activate AKT, PI3K activities in cells.
-
DescriptionRecilisib is a radioprotectant,can activate AKT, PI3K activities in cells.
-
SynonymsEx-RAD; ON 01210
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt;PI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number334969-03-8
-
Formula Weight336.8
-
Molecular FormulaC16H13ClO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:35.71 mg/mL (106.03 mM; Need ultrasonic)
-
SMILESC1=CC(=CC=C1CS(=O)(=O)/C=C/C2=CC=C(C=C2)C(=O)O)Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kang AD, et al. ON01210.Na (Ex-RAD) mitigates radiation damage through activation of the AKT pathway. PLoS One. 2013;8(3):e58355.
molnova catalog
related products
-
BAY-1125976
A potent and highly selective, allosteric AKT1/2 inhibitor with IC50 of 5.2/18 nM at 10 uM ATP.
-
Lenaldekar
Lenaldekar inhibits T-cell expansion and autoimmune encephalomyelitis.
-
Cariprazine
Cariprazine is a novel antipsychotic drug candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).
